Patent ID: 11969280
Assignee: CLEERLY, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  G  Y | IPC A  G

Claim 9:
10. A computer implemented method for generating a risk assessment of atherosclerotic cardiovascular disease (ASCVD) using the normalization device of claim 1, wherein normalization of the medical imaging improves accuracy of the algorithm-based imaging analysis, the method comprising:
receiving a first set of images of a first arterial bed and a first set of images of a second arterial bed, the second arterial bed being noncontiguous with the first arterial bed, and wherein at least one of the first set of images of the first arterial bed and the first set of images of the second arterial bed are normalized using the normalization device;
quantifying ASCVD in the first arterial bed using the first set of images of the first arterial bed;
quantifying ASCVD in the second arterial bed using the first set of images of the second arterial bed; and
determining a first ASCVD risk score based on the quantified ASCVD in the first arterial bed and the quantified ASCVD in the second arterial bed.